Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-01-01 @ 6:52 AM
Study NCT ID:
NCT00394459
Status:
COMPLETED
Last Update Posted:
2011-05-13
First Post:
2006-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D010292', 'term': 'Paresthesia'}], 'ancestors': [{'id': 'D020886', 'term': 'Somatosensory Disorders'}, {'id': 'D012678', 'term': 'Sensation Disorders'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 140}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2005-04'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2011-05', 'completionDateStruct': {'date': '2009-05', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2011-05-12', 'studyFirstSubmitDate': '2006-10-31', 'studyFirstSubmitQcDate': '2006-10-31', 'lastUpdatePostDateStruct': {'date': '2011-05-13', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2006-11-01', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2008-03', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'The primary end-point will be the incidence of spontaneous paraesthesia during catheter insertion in TEA-patients.', 'timeFrame': '1 hour'}], 'secondaryOutcomes': [{'measure': 'The frequency of inadvertent vascular cannulation', 'timeFrame': '1 hour'}, {'measure': 'Difficulties involved in insertion and removal of the catheter', 'timeFrame': '1 week'}, {'measure': 'Data on additional complications', 'timeFrame': '1 week'}, {'measure': 'Data for the evaluation of handling characteristics', 'timeFrame': '1 week'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Anaesthetic techniques', 'epidural', 'catheters', 'paraesthesia', 'side effects', 'Anesthesia, Epidural [E03.155.086.131]'], 'conditions': ['Anesthesia, Epidural', 'Paraesthesia']}, 'descriptionModule': {'briefSummary': 'Primary Objective: The primary objective is to demonstrate that the safety of Perifix New is non-inferior to using Perifix Standard when applied for thoracic epidural anaesthesia.\n\nPrimary Endpoint: Incidence of spontaneous paraesthesia during catheter insertion\n\nSecondary Objectives: The secondary objectives are to determine the safety and performance of the investigational product: frequency of inadvertent vascular cannulation, difficulties involved in insertion and removal of the catheter, other safety features and data for the evaluation of handling characteristics.\n\nTitle: Randomised, prospective, single-blind, controlled, study on the safety of two epidural catheters in patients undergoing surgery under thoracic epidural anaesthesia\n\nInvestigational Product: Perifix Epidural Anaesthesia Catheter\n\nTest Product: Perifix New\n\nReference Product: Perifix Standard\n\nNumber of Sites and Countries: 1 site in The Netherlands\n\nIndication: Thoracic epidural anaesthesia\n\nStudy Design: Randomised, prospective, single-blind, controlled study in 1 study center, phase IV\n\nPerifix New and Perifix Standard meet all the appropriate provisions of the relevant legislation implementing European Directives (both have CE-marking).\n\nStudy Duration: 2 year duration\n\nStudy Start: March-April 2005\n\nSample Size: n = 2\\*70 patients', 'detailedDescription': 'Epidural anaesthesia is a central neuraxial block technique with many applications. Improvements in equipment, drugs and technique have made it a popular and versatile anaesthetic technique, with applications in surgery, obstetrics and pain control. Both single injection and catheter techniques can be used. Its versatility means it can be used as an anaesthetic, as an analgesic adjuvant to general anaesthesia, and for postoperative analgesia in procedures involving the lower limbs, perineum, pelvis, abdomen and thorax.\n\nAlthough epidural anaesthesia is a safe technique, during the insertion of epidural catheters several side effects may occur, including transient paraesthesia and inadvertent vascular cannulation.\n\nReported incidences for paraesthesia vary widely between about 0.2% and 50% in different articles, depending on the catheter (catheter material, soft-tipped or firm-tipped catheter), the applied technique (lumbar or thoracic epidural anaesthesia, depth of catheter insertion), the approach (midline or paramedian) and the included patients (obstetrical or non-obstetrical). Paraesthesias are not supposed to lead to permanent neurological sequelae, but are unpleasant and perturbing sensations for the patient.\n\nBesides inadvertent intrathecal location of the catheter, further problems include technical difficulties during threading or removal of the catheter. Here, the catheter shaft material seems to be the crucial factor for the incidence of problems.\n\nBased upon years of experience, a wide range of epidural catheters were created, among them the Perifix catheter of B. Braun. Common features are their high tensile strength and stretch resistance, excellent shaft stability with easy visualisation of blood or spinal fluid due to the crystal clear material, no risk of forming loops or knots, and softening of catheter within a few hours due to water absorption of the polyamide material.\n\nRecently, B. Braun Melsungen AG has developed a new generation of Perifix epidural catheters, which are already CE-labeled. These new catheters are different in their composition compared to the current Perifix Standard catheter with regard to the catheter material and tip configuration. They have an outer poly-urethane liner and an inner polyamide body. Experimental tests have shown that the positive features (e.g. pushability, kink resistance, gliding, withdrawal) of the Perifix Standard catheter can be maintained. Due to the polyurethane outer layer, the catheter gets softer when reaching body temperature immediately upon insertion. Based on this, it is expected that paraesthesias during catheter injection can be reduced by at least 20%.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '75 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients scheduled for thoracic epidural anaesthesia (TEA), with or without general anaesthesia.\n* American Society of Anesthesiologists (ASA) class I-III\n* Patients aged 18 and ≤ 75 years of age\n\nExclusion Criteria:\n\n* Anamnestic exclusion criteria are all contraindications for epidural anaesthesia.\n* Severe scoliosis, previous surgery on the spine, M. Bechterew disease\n* Non-competent and non-cooperative patients\n* Patients with medicament and drug abuse problems, problems in communication, participating in parallel in another clinical study with experimental drugs or devices, receiving prohibited concomitant therapies'}, 'identificationModule': {'nctId': 'NCT00394459', 'briefTitle': 'Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA)', 'organization': {'class': 'OTHER', 'fullName': 'Maastricht University Medical Center'}, 'officialTitle': 'Randomised, Prospective, Single-blind, Controlled Multicenter Study on the Safety of Two Epidural Catheters in Patients Undergoing Surgery Under Thoracic Epidural Anaesthesia', 'orgStudyIdInfo': {'id': 'MEC 04-1-83'}, 'secondaryIdInfos': [{'id': 'H-04-078-04'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'A', 'description': 'Perifix Standard', 'interventionNames': ['Device: Perifix Epidural Anaesthesia Catheter', 'Device: Perifix Standard']}, {'type': 'EXPERIMENTAL', 'label': 'B', 'description': 'Perifix New', 'interventionNames': ['Device: Perifix Epidural Anaesthesia Catheter', 'Device: Perifix New']}], 'interventions': [{'name': 'Perifix Epidural Anaesthesia Catheter', 'type': 'DEVICE', 'description': 'Epidural Catheter', 'armGroupLabels': ['A', 'B']}, {'name': 'Perifix Standard', 'type': 'DEVICE', 'description': 'Perifix Standard', 'armGroupLabels': ['A']}, {'name': 'Perifix New', 'type': 'DEVICE', 'description': 'Perifix New', 'armGroupLabels': ['B']}]}, 'contactsLocationsModule': {'locations': [{'zip': '6202 AZ', 'city': 'Maastricht', 'country': 'Netherlands', 'facility': 'University Hospital Maastricht', 'geoPoint': {'lat': 50.84833, 'lon': 5.68889}}], 'overallOfficials': [{'name': 'Mathieu Gielen, MD, PhD', 'role': 'STUDY_CHAIR', 'affiliation': 'Radboud University Medical Center'}, {'name': 'Marco Marcus, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Maastricht University Medical Center'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Maastricht University Medical Center', 'class': 'OTHER'}, 'collaborators': [{'name': 'B. Braun Melsungen AG', 'class': 'INDUSTRY'}], 'responsibleParty': {'oldNameTitle': 'Marco Marcus', 'oldOrganization': 'MaastrichtUMC'}}}}